The discovery of the DNA structure sparked a flurry of new research, birthing fields like molecular biology, biotechnology, ...

Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acurx" or the "Company"), a late-stage biopharmaceutical company developing a new class of small molecule antibiotics for difficult-to-treat bacterial ...

Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acurx" or the "Company"), a late-stage biopharmaceutical company developing a new class of antibiotics for difficult-to-treat bacterial infections, ...

Hilariously and without realizing it, antivaxxer Steve Kirsch nailed the essence of why a recent antivax "report" by the ...

A new wave of digital sweepstakes has pushed backend engineering into the spotlight. What used to be a simple marketing ...